Lv51
1068 积分 2025-12-29 加入
Oligonucleotide (OLIGO) Drugs
1小时前
已完结
Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides
2小时前
已完结
Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides:Physicochemical Characteristics and Beyond
2小时前
已完结
Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system
8天前
已完结
Neutral BackboneModifications Enhance the Pharmacokineticsand Biodistribution of Antibody–Oligonucleotide Conjugateswith High Drug-to-Antibody Ratios
9天前
已完结
Phosphorothioate-Free and Self-Interaction-Reduced Acyclic Nucleic Acids for Effective Antisense Oligonucleotide
10天前
已完结
RModBlock antisense oligonucleotides as a universal tool for precise and efficient inhibition of RNA modifications
10天前
已完结
From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization
11天前
已完结
Recent advances in the analysis of the evolutionary RNA based therapeutics; a review
14天前
已完结
Targeted Delivery of Oligonucleotide–Peptide Conjugates for Enhanced Kidney-Specific Therapy
15天前
已完结
皖公网安备34019202002308
